Beam Therapeutics Inc (NAS:BEAM)

$ 27.08 0.72 (2.73%) Market Cap: 2.24 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.82 GF Score: 54/100

Q3 2024 Beam Therapeutics Inc Earnings Call Transcript
Nov 05, 2024

$23.93 (-1.77%)

Earnings
Beam Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Beam Therapeutics Inc at Citi BioPharma Conference Transcript
Sep 07, 2023
Beam Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) Transcript
May 30, 2023
Beam Therapeutics Inc at Barclays Virtual Gene Editing & Therapy Summit Transcript
May 24, 2023
Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2023
Beam Therapeutics Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) Transcript
Apr 03, 2023
Beam Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Mar 16, 2023
Beam Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022
Beam Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Dec 01, 2022
Beam Therapeutics Inc at Jefferies London Healthcare Conference Transcript
Nov 15, 2022
Beam Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 08, 2022
Beam Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 17, 2022
Beam Therapeutics Inc at Bank of America Healthcare Conference Transcript
May 11, 2022
Beam Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Oct 27, 2021
Beam Therapeutics Inc at Chardan Genetic Medicines Conference (Virtual) Transcript
Oct 05, 2021
Beam Therapeutics Inc at William Blair Biotech Focus Conference (Virtual) Transcript
Jul 15, 2021
Beam Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 11, 2021
Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021

Q3 2024 Beam Therapeutics Inc Earnings Call Transcript

Nov 05, 2024 / 01:30PM GMT

Release Date Price: $23.93 (-1.77%)

Transcript 10-Q8-K

Operator

Good morning, and welcome to the Beam Therapeutics Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Beam's request.

I would now like to turn the call over to Holly Manning, Vice President of Investor Relations and External Communications.

Holly Manning

Beam Therapeutics Inc - Vice President of Investor Relations & External Communications

Thank you, operator. Good morning, everyone, and welcome to Beam's conference call to review third quarter 2024 business update, including Abstracts Accepted for Presentation at the American Society of Hematology Annual Meeting. You can access slides for today's call by going to the Investors section of our website, bmtx.com.

With me on the call today with prepared remarks are John Evans, our Chief Executive Officer; Dr. Giuseppe Ciaramella, our President; and Dr. Amy Simon, our Chief Medical Officer.

Before we get started, I would like to remind everyone that

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.